ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9346
-0.29%
Brent Oil
83.525
0.48%
Bitcoin
64,263.21
0.41%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) Noticias

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:AZN
FechaHoraFuenteTítuloSímboloCompañía
06/05/202401:46Alliance NewsAlliance NewsAstraZeneca completes collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
02/05/202404:04Alliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
02/05/202401:00RNS Regulatory NewsAstraZeneca PLC Calquence combination improved PFS in 1L MCLLSE:AZNAstrazeneca Plc
01/05/202409:00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
29/04/202403:13Alliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
29/04/202401:05RNS Regulatory NewsAstraZeneca PLC Truqap recommended for EU breast cancer approvalLSE:AZNAstrazeneca Plc
29/04/202401:00RNS Regulatory NewsAstraZeneca PLC Enhertu improved PFS in HER2-low and ultralowLSE:AZNAstrazeneca Plc
25/04/202407:00PR Newswire (US)AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingLSE:AZNAstrazeneca Plc
25/04/202403:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growthLSE:AZNAstrazeneca Plc
25/04/202401:00RNS Regulatory NewsAstraZeneca PLC 1st Quarter ResultsLSE:AZNAstrazeneca Plc
24/04/202404:32Alliance NewsAlliance NewsAngle shares jump on supplier agreement with with AstraZenecaLSE:AZNAstrazeneca Plc
16/04/202405:38Alliance NewsAlliance NewsIN THE KNOW: Deutsche ups AstraZeneca as higher payout addresses worryLSE:AZNAstrazeneca Plc
16/04/202402:39Alliance NewsAlliance NewsAstraZeneca's hails Imfinzi survival data on cancer formLSE:AZNAstrazeneca Plc
11/04/202411:42Alliance NewsAlliance News*AstraZeneca AGM resolutions pass, but 36% vote against remuneration policyLSE:AZNAstrazeneca Plc
11/04/202411:30RNS Regulatory NewsAstraZeneca PLC Result of AGMLSE:AZNAstrazeneca Plc
11/04/202402:56Alliance NewsAlliance NewsTOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023LSE:AZNAstrazeneca Plc
11/04/202401:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca increases 2024 dividend by 7%LSE:AZNAstrazeneca Plc
08/04/202402:36Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails neurological data for Ultomiris, SolirisLSE:AZNAstrazeneca Plc
08/04/202401:00RNS Regulatory NewsAstraZeneca PLC Enhertu approved in US for HER2+ solid tumoursLSE:AZNAstrazeneca Plc
08/04/202400:53Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approvalLSE:AZNAstrazeneca Plc
05/04/202403:42Alliance NewsAlliance NewsAstraZeneca makes "breakthrough" in treating small cell lung cancerLSE:AZNAstrazeneca Plc
05/04/202401:00RNS Regulatory NewsAstraZeneca PLC Imfinzi improved OS & PFS in limited-stage SCLCLSE:AZNAstrazeneca Plc
03/04/202405:02Alliance NewsAlliance NewsCORRECT: AstraZeneca, Daiichi make US progress with licence approvalsLSE:AZNAstrazeneca Plc
02/04/202404:25Alliance NewsAlliance NewsAstraZeneca and Daiichi make US progress with latest licence approvalsLSE:AZNAstrazeneca Plc
02/04/202401:05RNS Regulatory NewsAstraZeneca PLC Voydeya approved in USLSE:AZNAstrazeneca Plc
02/04/202401:00RNS Regulatory NewsAstraZeneca PLC FDA accepts Dato-DXd BLA for breast cancerLSE:AZNAstrazeneca Plc
27/03/202404:19Alliance NewsAlliance NewsAstraZeneca treatments become "first and only" to be approved in JapanLSE:AZNAstrazeneca Plc
25/03/202403:40Alliance NewsAlliance NewsTOP NEWS: AstraZeneca wins US approval for rare nervous system diseaseLSE:AZNAstrazeneca Plc
25/03/202402:00RNS Regulatory NewsAstraZeneca PLC Ultomiris approved in the US for NMOSDLSE:AZNAstrazeneca Plc
21/03/202411:43Alliance NewsAlliance NewsAstraZeneca's Tagrisso successful in treating lung cancerLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Su Consulta Reciente

NYSE
AXP
American Express
USI
USTECH100
US Tech 100
NYSE
MRK
Merck
COIN
SOLUSD
Solana
USOTC
RHHBY
Roche (QX)
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
CCOM
OILBRENT
Brent Oil
AMEX
SPY
SPDR S&P 500
COIN
BTCUSD
Bitcoin
NYSE
VZ
Verizon Communications
SPI
SP500
S&P 500
CCOM
US30
US 30
NASDAQ
MSFT
Microsoft
NYSE
CVX
Chevron
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados